Otolaryngology/Head and Neck (all articles)
RCT: Time to functional recovery after laser tonsillotomy performed under local anesthesia vs. conventional tonsillectomy with general anesthesia among adults.
22 Feb, 2022 | 08:22h | UTC
Commentary on Twitter
RCT found laser tonsillotomy under local anesthesia had faster functional recovery but lower resolution of the chief complaint leading to surgery vs conventional tonsillectomy under general anesthesia; it may offer a feasible alternative. https://t.co/yfaWeFJeEl pic.twitter.com/DDYxlEhZEp
— JAMA Network Open (@JAMANetworkOpen) February 21, 2022
Consensus Statement: Head and neck cancer survivorship.
16 Feb, 2022 | 08:49h | UTCRelated:
Head and Neck Cancer Survivorship Care Guideline
American Cancer Society Head and Neck Cancer Survivorship Care Guideline
ED management of the post-laryngectomy patient.
13 Feb, 2022 | 21:44h | UTCED Management of the Post-Laryngectomy Patient – emDocs
ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
11 Feb, 2022 | 08:23h | UTC
Clinical practice guideline on tympanostomy tubes in children.
10 Feb, 2022 | 10:10h | UTC
Therapies for Olfactory Dysfunction — an Update.
7 Feb, 2022 | 08:29h | UTCTherapies for Olfactory Dysfunction — an Update – Current Allergy and Asthma Reports (if the link is paywalled, try this one)
M-A of 26 observational studies found hearing loss and dual sensory loss are linked to excess all-cause and cardiovascular mortality.
3 Feb, 2022 | 08:22h | UTCAssociations of Hearing Loss and Dual Sensory Loss With Mortality: A Systematic Review, Meta-analysis, and Meta-regression of 26 Observational Studies With 1 213 756 Participants – JAMA Otolaryngology—Head & Neck Surgery (link to abstract – $ for full-text)
Author Interview: Associations of Hearing Loss and Dual Sensory Loss With Mortality
[Preprint] High prevalence of olfactory disorders 18 months after contracting COVID-19.
26 Jan, 2022 | 02:11h | UTCHigh prevalence of olfactory disorders 18 months after contracting COVID-19 – medRxiv
Commentaries:
Half of first-wave Covid cases may have lasting harm to sense of smell – The Guardian
Prevalence of olfactory dysfunction 18 months after SARS-CoV-2 infection – News Medical
Systematic Review: Oral antihistamine‐decongestant‐analgesic combinations for the common cold.
26 Jan, 2022 | 01:31h | UTCOral antihistamine‐decongestant‐analgesic combinations for the common cold – Cochrane Library
Commentary: Oral antihistamine-decongestant-analgesic combinations for the common cold – Cochrane Library
Systematic Review: Chemotherapy for the treatment of oral cavity and oropharyngeal cancer.
13 Jan, 2022 | 08:14h | UTCSummary: Chemotherapy for mouth and throat cancer – Cochrane Library
RCT: Endoscopic sinus surgery with medical therapy vs. medical therapy alone for chronic rhinosinusitis with nasal polyps.
12 Jan, 2022 | 08:51h | UTCEndoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)
Commentary on Twitter
NEW Research—Endoscopic sinus surgery + medical therapy > medical therapy alone in pts w/ chronic rhinosinusitis w/ nasal polyps (although minimal clinically important difference was not met)
From Wytske Fokkens & colleagues https://t.co/VKxCQZ97Am pic.twitter.com/IzXq712lNL
— The Lancet Respiratory Medicine (@LancetRespirMed) January 8, 2022
Systematic Review: Antibiotics for adults and children with sore throats.
10 Dec, 2021 | 10:02h | UTCSummary: Antibiotics for adults and children with sore throats – Cochrane Library
Original Research: Antibiotics for treatment of sore throat in children and adults – Cochrane Library
The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.
7 Dec, 2021 | 10:23h | UTCRelated:
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.
Position statement: Perioperative management of post-COVID-19 surgical patients.
Choosing Wisely: Nine pediatric otolaryngology recommendations.
9 Nov, 2021 | 01:09h | UTCSee complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada
Choosing Wisely for Thyroid Conditions: Ten things clinicians and patients should question – “Do not order thyroid ultrasound for nodule detection in patients without thyroid anatomic anomalies on clinical examination”.
9 Nov, 2021 | 01:11h | UTCSee complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada
Retrospective cohort study: corticosteroid treatment linked to lower odds of surgical drainage among pediatric patients with retropharyngeal and parapharyngeal abscesses.
28 Oct, 2021 | 09:52h | UTC
Clinical Report | Topical nasal decongestant Oxymetazoline: safety considerations for perioperative pediatric use.
6 Oct, 2021 | 10:01h | UTC
AHA Scientific Statement: Sleep‐disordered breathing and cardiovascular disease in children and adolescents.
23 Sep, 2021 | 10:02h | UTCNews release: Obstructive sleep apnea is common in kids and may impact blood pressure, heart health – American Heart Association
RCT: Prophylactic steroids prevent hypocalcemia and voice dysfunction in patients undergoing thyroidectomy.
15 Sep, 2021 | 08:44h | UTCUse of Prophylactic Steroids to Prevent Hypocalcemia and Voice Dysfunction in Patients Undergoing Thyroidectomy: A Randomized Clinical Trial – JAMA Otolaryngology – Head & Neck Surgery (link to abstract – $ for full-text)
Author interview: Prophylactic Steroids for Postthyroidectomy Hypocalcemia and Voice Dysfunction
Commentary: IV Steroid Before Thyroidectomy Prevents Complications — One dose of dexamethasone reduced hypocalcemia, voice issues – MedPage Today (free registration required)
Commentary on Twitter
This RCT with 192 patients found that pre-op dexamethasone resulted in a reduction in hypocalcemia at 24 hrs post-op by 24% and reduction in voice dysfunction at 24 hrs by 25%. Strong evidence in supporting a pre-op 8mg dose of dexamethasone @JAMAOto https://t.co/UIt18DXclN
— Jay Piccirillo, MD (@PiccirilloJay) September 5, 2021
Differentiating central from peripheral causes of acute vertigo in an emergency setting with the HINTS, STANDING, and ABCD2 tests: A diagnostic cohort study.
6 Sep, 2021 | 10:36h | UTCDifferentiating central from peripheral causes of acute vertigo in an emergency setting with the HINTS, STANDING, and ABCD2 tests: A diagnostic cohort study – Academic Emergency Medicine (link to abstract – $ for full-text)
Commentary: Can We Detect Central Vertigo on Exam? – Journal Feed
Study: Macrolide use significantly associated with both prevalent and incident tinnitus.
22 Aug, 2021 | 22:11h | UTCCommentary: Macrolide Use and Tinnitus: A New Safety Ringtone? – NEJM Journal Watch (free for a limited period)
ASCO Guideline: Salivary gland hypofunction and/or xerostomia induced by nonsurgical cancer therapies.
19 Aug, 2021 | 08:50h | UTC
Review: Initial management of blunt and penetrating neck trauma.
17 Aug, 2021 | 08:40h | UTCInitial management of blunt and penetrating neck trauma – BJA Education
Clinical Picture: Mucormycosis after COVID-19 in a patient with diabetes.
6 Aug, 2021 | 10:09h | UTCMucormycosis after COVID-19 in a patient with diabetes – The Lancet
Related:
COVID-19 and mucormycosis superinfection: the perfect storm.
What is mucormycosis, the fungal infection affecting COVID patients in India?
[Preprint] The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries.
Mucormycosis: The ‘black fungus’ maiming Covid patients in India
Global Guideline for the Diagnosis and Management of Mucormycosis
Post-viral effects of COVID-19 in the olfactory system and their implications.
2 Aug, 2021 | 00:24h | UTCPost-viral effects of COVID-19 in the olfactory system and their implications – The Lancet Neurology
Related:
Study finds 96.1% of patients objectively recovered from anosmia 1 year after COVID-19 diagnosis.
Loss of smell in mild Covid-19 cases occurs 86% of the time, study says
Management of anosmia and loss of smell in the era of Covid-19